-
Post date
December 29, 2023
-
Posted by
GaalenEngen
-
Posted in
Antidepressant Efficacy, Canadian healthcare, Core Story, Depression in Canada, Health Science, Investment Opportunities in Healthcare, mdma for ptsd, Mental Health Awareness, Mental Health Care, Mental Health Crisis, Mental Health Disorders, Mental Health Policy, Mental Health Statistics, Mushrooms, Optimi Health Corp., Optimi Health Developments, Pharmaceutical Innovation, psychedelic assisted therapy, Psychedelic Drug Candidates, Psychedelics, Today's Idea, Treatment-resistant Depression, Wellness
-
Post date
January 19, 2022
-
Posted by
Kieran Robertson
-
Posted in
MAPPUSX, maps mdma phase 3 study, maps mdma study, maps mdma study phase 3, maps phase 3 mdma ptsd, mdma assisted therapy canada, mdma for ptsd, mdma for ptsd maps study, mdma ptsd studies, MDMA Therapy, MDMA-assisted therapy, Multidisciplinary Association for Psychedelic Studies, NUMI.T, Numinus Wellness Inc., Numinus Wellness Inc. (NUMI.T), Psychedelics
